NCT03729765View on ClinicalTrials.gov

Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 19, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

December 31, 2023

Conditions
Cardiogenic Shock
Interventions
DEVICE

hemoperfusion

The patients in the simultaneous hemoperfusion arm will receive hemoperfusion when extracorporeal membrane oxygenation (ECMO) is commenced. veno-arterial extracorporeal membrane oxygenation (VA-ECMO) patients treat with hemoperfusion three times in a row，each time for 6 hours.

Trial Locations (1)

100029

RECRUITING

Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER